Silo Pharma Inc. (NASDAQ: SILO)
$2.58
+1.5100 ( +141.12% ) 175.0M
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Market Data
Open
$2.58
Previous close
$1.07
Volume
175.0M
Market cap
$8.81M
Day range
$1.07 - $2.67
52 week range
$0.84 - $3.05
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jul 08, 2024 |
8-k | 8K-related | 14 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 13, 2024 |
8-k | 8K-related | 22 | Jun 06, 2024 |
8-k | 8K-related | 14 | Jun 04, 2024 |
10-q | Quarterly Reports | 59 | May 13, 2024 |
4 | Insider transactions | 1 | Apr 08, 2024 |
8-k | 8K-related | 13 | Apr 05, 2024 |
4 | Insider transactions | 1 | Apr 01, 2024 |
10-k | Annual reports | 74 | Mar 25, 2024 |